Trade Ideas November 11, 2026 01:04 AM

Celestica: Oversold AI Play with Deep Value and a Clear Rebound Path

Balance-sheet strength, AI networking exposure and a beaten-down multiple create a high-conviction swing trade.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
CLS

Celestica (CLS) looks attractively priced after a sizeable multi-month selloff. The business sits squarely in AI networking and data-center manufacturing, and the stock trades at a reasonable multiple vs. its cash flow and growth signals. We outline a clear entry, stop and target for a mid-term swing trade and highlight catalysts and risks that could move the stock back toward its former highs.

Celestica: Oversold AI Play with Deep Value and a Clear Rebound Path
CLS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Celestica sits at the intersection of contract manufacturing and AI networking - a direct beneficiary of accelerated data-center spend.
  • Company shows healthy fundamentals: roughly $545M in free cash flow, ROE ~20% and low leverage (debt/equity ~0.13).
  • Valuation is compressed relative to recent highs; EV/EBITDA ~14.7x and trailing P/E ~21x while the stock trades near $229.
  • Actionable swing trade: entry $229.15, stop $197.50 (52-week low), target $350.00, horizon mid term (45 trading days).

Hook & thesis

Celestica has been punished in the recent AI tech rotation: the share price sits near $229 following a 40% decline over the past year versus a 17.9% drop for peers. That selling has created an asymmetrical opportunity. The company combines a strong balance sheet, positive free cash flow and clear exposure to high-value AI networking and data-center programs - all while the stock trades at a single-digit-ish EV/sales footprint and mid-teens to low-20s P/E depending on the snapshot. For attentive traders willing to tolerate near-term volatility, Celestica offers an actionable long trade with defined risk.

My read: the market has overshot on near-term weakness while underpricing accelerating demand for AI networking products (including new 1.6T switches) and the potential for sizable earnings revisions in 2026-2027. If those top-line and margin dynamics reaccelerate, the stock has a clear runway to re-rate.

What Celestica does and why investors should care

Celestica is a global provider of manufacturing and supply-chain services to equipment manufacturers and service providers. Its operations run through two main segments: Advanced Technology Solutions (ATS) - which covers aerospace, defense, industrial and health-tech - and Connectivity and Cloud Solutions (CCS) - which covers enterprise communications, telecommunications, servers and storage. The company is a key contract manufacturer and integrator for components and systems that feed AI infrastructure.

Why the market should care now: revenue pools tied to AI networking and hyperscale data centers are growing fast, and Celestica is positioned on both the manufacturing and systems-integration sides of that stack. Recent industry commentary highlights stronger demand for AI networking products and next-generation switches - a direct positive for Celestica's CCS backlog and revenue mix. If Celestica captures a meaningful share of accelerated AI capex, top-line growth and margin expansion could follow.

Hard numbers that support the trade thesis

Metric Value
Current price $229.15
Market cap $28.24B
P/E (trailing) ~21.1x
EV / EBITDA 14.7x
Free cash flow (annual) $545.4M
ROE 20.05%
Debt / Equity 0.13
52-week range $197.50 - $474.03
Shares outstanding ~126.1M

Those numbers tell a mixed but interesting story. Celestica generates meaningful free cash flow - roughly $545M on the most recent annual basis - and the balance sheet is conservative with debt-to-equity at ~0.13. Return on equity is strong at ~20% which speaks to solid operating returns. At a market cap of roughly $28.24B and enterprise value near $24.97B, the valuation is not bargain-basement cheap in absolute terms, but it is compressed relative to the company’s recent trading band and relative to the growth opportunity embedded in AI infrastructure.

Why valuation feels 'crushed' today

Two forces pushed the stock lower: a sector-wide re-pricing and company-specific profit-taking after the stock traded near $474 earlier in the year. Technical indicators show the stock is trading well below moving averages (10-, 20-, 50-day SMAs are $245, $268 and $314 respectively) and momentum is soft (RSI ~35.55, MACD in bearish momentum), which explains part of the sentiment drag.

But the core fundamentals - rising analyst earnings revisions for 2026 and 2027 (reported upgrades of roughly +40.9% and +87.2% respectively in recent coverage) - suggest revenue and earnings upside is not fully reflected in the current multiple. If Celestica recovers even a portion of its growth multiple as visibility into AI-related revenue improves, upside could be material.

Catalysts that can drive a re-rating

  • Stronger-than-expected AI networking orders - visible through quarterly bookings and commentary. The market is particularly focused on demand for new 1.6T switches and related modules.
  • Quarterly earnings beats and upward guidance revisions - analysts have already been raising 2026-27 estimates; continued upward revisions would force revaluation.
  • Margin expansion via higher mix of CCS/AI work and operational leverage - Celestica’s ability to move mix to higher-margin systems and services could lift EBITDA multiples.
  • Large customer wins or design-ins announced publicly - any multi-quarter contract wins with hyperscalers or telecom OEMs would be a clear positive.

Trade plan (actionable)

Trade direction: Long

Entry price: $229.15

Stop loss: $197.50 (the 52-week low) - if the stock revisits that low, it signals either renewed macro weakness or a loss of material customer programs and I would exit.

Target price: $350.00 - this is a mid-sized re-rating toward historical highs and partial recovery of the multiple as AI demand visibly strengthens. This target implies roughly ~53% upside from entry and is conservative versus the 52-week high of $474.

Horizon: mid term (45 trading days). I expect two to six quarters of clearer order-flow commentary to show up in quarterly reports and conference calls, and the 45-trading-day horizon is a practical swing period to capture an initial re-rating or a short-term sentiment rebound. If the trade reaches the target before that window, tighten stops and scale out.

Position sizing note: Given the stock's volatility and sector risk, I would allocate a position size consistent with a medium-risk trade - something that represents a single-digit percentage of portfolio capital for most retail traders.

Risks & counterarguments

  • Execution risk: Winning AI networking programs does not guarantee margin expansion. Manufacturing scale-up for complex switches and optics can compress margins if Celestica misjudges cost or timing.
  • Concentration/Customer risk: A small number of large customers can swing quarterly results. Any lost design-win or program delay at a hyperscaler or telecom customer would materially impact revenue.
  • Macro and capex cycles: A broader pullback in hyperscaler capex or delayed AI infrastructure spending would pressure bookings and re-rate multiples lower.
  • Valuation reset risk: The stock still trades at an EV/EBITDA of ~14.7x and a P/E ~21x; if the market applies a lower multiple to manufacturing-heavy names, gains could be limited even with modest growth.
  • Technical headwinds: Momentum indicators are weak (RSI ~35.5, bearish MACD) and moving averages sit well above the current price; there’s a risk of continued mean-reversion lower before any durable recovery.

Counterargument: Some investors will argue that the stock’s fall reflects fundamental weakness rather than sentiment - i.e., demand normalization for certain legacy connectivity products and margin pressure from rising input costs. That’s plausible. If Celestica’s revenue composition shifts away from high-value AI work or if competitive pricing erodes margins, the multiple will compress further and the trade would fail. I put that in the risk bucket and protect against it with the $197.50 stop.

What would change my mind

I would reconsider the long stance if any of the following happen: a) consistent signs of lost design-ins or cancellations from major customers; b) evidence of margin deterioration through a quarter (material negative surprise to EBITDA or free cash flow); or c) a macro freeze that forces hyperscalers to materially cut AI capex. Conversely, repeated beats to revenue and EPS with positive guidance would strengthen the thesis and justify adding to the position or extending the time horizon to a position trade (180 trading days).

Conclusion

Celestica is a pragmatic, balance-sheet-healthy industrial tech company at the intersection of contract manufacturing and AI infrastructure. The market has punished the stock aggressively, and that creates an actionable risk/reward skew for a disciplined swing trader. The combination of visible free cash flow (~$545M), conservative leverage (debt-to-equity ~0.13), and upward earnings revisions for 2026-27 are the core pillars supporting this long trade. Entry at $229.15, a stop at $197.50 and a target of $350 gives a well-defined plan: the upside is large if AI demand and margin mix improve, and downside is limited by the stop set at the 52-week low.

If you take the trade, manage size, watch quarterly order flow closely and be prepared to tighten stops on positive news or cut losses if customer/program signals deteriorate.

Risks

  • Execution risk on complex AI networking manufacturing can compress margins if scale-up issues occur.
  • Customer concentration - loss or delay at a major customer could materially impact quarterly revenue.
  • Sector/capex cyclicality - a pullback in hyperscaler AI spending would depress bookings and valuation.
  • Technical and momentum risk - current indicators are weak and the stock could revisit lows before re-rating.

More from Trade Ideas

Buy Gen Digital on Guidance Momentum — Trading the Re-rate at ~10x FY27 EPS Nov 11, 2026 Root's Profitability Run and Cheap Valuation Make This a High-Conviction Buy Nov 11, 2026 Nano Labs: Microcap Optionality — A High-Risk Long on AI + Crypto Recovery Nov 10, 2026 Buy Scotiabank Ahead of Q4: Dividend Income Plus Upside If Results Beat Nov 10, 2026 Buying the Panic: Amdocs' 30% Plunge Clears a Window for a High-Reward Speculative Long Nov 10, 2026